Advertisement
Screener

VERICEL CORPORATION (VCEL) Material Contracts

VERICEL CORPORATION Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2025-07-31: Form 10-Q; Exhibit 10.1; Description Amended and Restated Non-Employee Director Compensation Guidelines, revised April 30, 2025..
  • 2025-05-08: Form 10-Q; Exhibit 10.1; Description Employment Agreement, by and between Karen Mahoney and the Company, dated July 24, 2024..
  • 2025-05-02: Form 8-K; Exhibit 10.2; Description Vericel Corporation Amended and Restated 2015 Employee Stock Purchase Plan.
  • 2025-05-02: Form 8-K; Exhibit 10.1; Description Vericel Corporation Amended and Restated 2022 Omnibus Incentive Plan.
FiledFormExhibitDescription
2025-07-3110-Q10.1Amended and Restated Non-Employee Director Compensation Guidelines, revised April 30, 2025.
2025-05-0810-Q10.1Employment Agreement, by and between Karen Mahoney and the Company, dated July 24, 2024.
2025-05-028-K10.2Vericel Corporation Amended and Restated 2015 Employee Stock Purchase Plan
2025-05-028-K10.1Vericel Corporation Amended and Restated 2022 Omnibus Incentive Plan
2025-02-2710-K10.34Ninth Amendment to the Distribution Agreement between Orsini Pharmaceutical Services, Inc. and the Company, dated May 15, 2024.
2025-02-2710-K10.7First Amendment to the Lease Agreement by and between the Company and NDB Property Owner 2, L.P., dated November 6, 2024.

Similar stocks

Stock NameCountryMarket CapPE Ratio
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Greenland Mines Ltd (GRML)United States$2.362B
Immunocore Holdings plc (IMCR)$1.613B-90.43
Taysha Gene Therapies, Inc. (TSHA)United States$1.564B-14.80